BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9756741)

  • 1. Renaturation of recombinant human neurotrophin-3 from inclusion bodies using a suppressor agent of aggregation.
    Suenaga M; Ohmae H; Tsuji S; Itoh T; Nishimura O
    Biotechnol Appl Biochem; 1998 Oct; 28 ( Pt 2)():119-24. PubMed ID: 9756741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refolding of therapeutic proteins produced in Escherichia coli as inclusion bodies.
    Misawa S; Kumagai I
    Biopolymers; 1999; 51(4):297-307. PubMed ID: 10618597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized procedure for renaturation of recombinant human bone morphogenetic protein-2 at high protein concentration.
    Vallejo LF; Rinas U
    Biotechnol Bioeng; 2004 Mar; 85(6):601-9. PubMed ID: 14966801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refolding and purification of Zymomonas mobilis levansucrase produced as inclusion bodies in fed-batch culture of recombinant Escherichia coli.
    Sunitha K; Chung BH; Jang KH; Song KB; Kim CH; Rhee SK
    Protein Expr Purif; 2000 Apr; 18(3):388-93. PubMed ID: 10733894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refolding and purification of recombinant human PDE7A expressed in Escherichia coli as inclusion bodies.
    Richter W; Hermsdorf T; Kronbach T; Dettmer D
    Protein Expr Purif; 2002 Jun; 25(1):138-48. PubMed ID: 12071709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renaturation of Escherichia coli-derived recombinant human macrophage colony-stimulating factor.
    Tran-Moseman A; Schauer N; De Bernardez Clark E
    Protein Expr Purif; 1999 Jun; 16(1):181-9. PubMed ID: 10336876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and renaturation of recombinant human lymphotoxin (tumour necrosis factor beta) expressed in Escherichia coli as inclusion bodies.
    Jin H; Uddin MS; Huang YL; Teo WK
    J Chem Technol Biotechnol; 1994 Jan; 59(1):67-72. PubMed ID: 7764497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refolding and purification of yeast carboxypeptidase Y expressed as inclusion bodies in Escherichia coli.
    Hahm MS; Chung BH
    Protein Expr Purif; 2001 Jun; 22(1):101-7. PubMed ID: 11388806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning, expression, and refolding of a secretory protein ESAT-6 of Mycobacterium tuberculosis.
    Wang BL; Xu Y; Wu CQ; Xu YM; Wang HH
    Protein Expr Purif; 2005 Feb; 39(2):184-8. PubMed ID: 15642469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct refolding of inclusion bodies using reversed micelles.
    Sakono M; Kawashima YM; Ichinose H; Maruyama T; Kamiya N; Goto M
    Biotechnol Prog; 2004; 20(6):1783-7. PubMed ID: 15575712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and renaturation of bio-active proteins expressed in Escherichia coli as inclusion bodies.
    Fischer B; Sumner I; Goodenough P
    Arzneimittelforschung; 1992 Dec; 42(12):1512-5. PubMed ID: 1288517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the potential refolding yield of recombinant proteins expressed as inclusion bodies.
    Ho JG; Middelberg AP
    Biotechnol Bioeng; 2004 Sep; 87(5):584-92. PubMed ID: 15352056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro refolding of carboxypeptidase T precursor from Thermoactinomyces vulgaris obtained in Escherichia coli as cytoplasmic inclusion bodies.
    Trachuk L; Letarov A; Kudelina IA; Yusupova MP; Chestukhina GG
    Protein Expr Purif; 2005 Mar; 40(1):51-9. PubMed ID: 15721771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advances in in vitro refolding of inclusion body proteins].
    Fang M; Huang HL
    Sheng Wu Gong Cheng Xue Bao; 2001 Nov; 17(6):608-12. PubMed ID: 11910749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative refolding of recombinant prochymosin.
    Wei C; Tang B; Zhang Y; Yang K
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):345-51. PubMed ID: 10229691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renaturation of casein kinase II from recombinant subunits produced in Escherichia coli: purification and characterization of the reconstituted holoenzyme.
    Lin WJ; Traugh JA
    Protein Expr Purif; 1993 Jun; 4(3):256-64. PubMed ID: 8390882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The propeptide is not required to produce catalytically active neutral protease from Bacillus stearothermophilus.
    Mansfeld J; Petermann E; Dürrschmidt P; Ulbrich-Hofmann R
    Protein Expr Purif; 2005 Feb; 39(2):219-28. PubMed ID: 15642473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Isolation, purification and renaturation of recombinant-DNA-derived porcine somatotropin].
    Li Z; Yu RS; Liu HL; Wang Y; Zhang P; Zhou ZA; Zhang DF
    Sheng Wu Gong Cheng Xue Bao; 2001 Nov; 17(6):703-5. PubMed ID: 11910769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro-sequence assisted folding and disulfide bond formation of human nerve growth factor.
    Rattenholl A; Ruoppolo M; Flagiello A; Monti M; Vinci F; Marino G; Lilie H; Schwarz E; Rudolph R
    J Mol Biol; 2001 Jan; 305(3):523-33. PubMed ID: 11152610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of arginine in protein refolding, solubilization, and purification.
    Tsumoto K; Umetsu M; Kumagai I; Ejima D; Philo JS; Arakawa T
    Biotechnol Prog; 2004; 20(5):1301-8. PubMed ID: 15458311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.